SG11202005264PA - Pyrrolo(pyrazolo)pyrimidine derivative as lrrk2 inhibitor - Google Patents
Pyrrolo(pyrazolo)pyrimidine derivative as lrrk2 inhibitorInfo
- Publication number
- SG11202005264PA SG11202005264PA SG11202005264PA SG11202005264PA SG11202005264PA SG 11202005264P A SG11202005264P A SG 11202005264PA SG 11202005264P A SG11202005264P A SG 11202005264PA SG 11202005264P A SG11202005264P A SG 11202005264PA SG 11202005264P A SG11202005264P A SG 11202005264PA
- Authority
- SG
- Singapore
- Prior art keywords
- pyrazolo
- pyrrolo
- pyrimidine derivative
- lrrk2 inhibitor
- lrrk2
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762594773P | 2017-12-05 | 2017-12-05 | |
| PCT/KR2018/015184 WO2019112269A1 (en) | 2017-12-05 | 2018-12-03 | Pyrrolo(pyrazolo)pyrimidine derivative as lrrk2 inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202005264PA true SG11202005264PA (en) | 2020-07-29 |
Family
ID=66751116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202005264PA SG11202005264PA (en) | 2017-12-05 | 2018-12-03 | Pyrrolo(pyrazolo)pyrimidine derivative as lrrk2 inhibitor |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11370796B2 (en) |
| EP (1) | EP3722298B1 (en) |
| JP (1) | JP7230053B2 (en) |
| KR (1) | KR20200085779A (en) |
| CN (1) | CN111433208B (en) |
| AU (1) | AU2018381574B2 (en) |
| CA (1) | CA3083583A1 (en) |
| EA (1) | EA202091372A1 (en) |
| MX (1) | MX2020005866A (en) |
| SG (1) | SG11202005264PA (en) |
| WO (1) | WO2019112269A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018381574B2 (en) * | 2017-12-05 | 2022-09-15 | Oscotec Inc. | Pyrrolo(pyrazolo)pyrimidine derivative as LRRK2 inhibitor |
| TW202110849A (en) * | 2019-05-27 | 2021-03-16 | 大陸商迪哲（江蘇）醫藥股份有限公司 | Dna-dependent protein kinase inhibitor |
| US20230357269A1 (en) | 2020-05-06 | 2023-11-09 | Les Laboratoires Servier | New macrocyclic lrrk2 kinase inhibitors |
| TW202304935A (en) | 2021-03-18 | 2023-02-01 | 法商施維雅藥廠 | New macrocyclic lrrk2 kinase inhibitors |
| CN113880844B (en) * | 2021-09-29 | 2023-02-14 | 武汉九州钰民医药科技有限公司 | Chemical synthesis method of Wee1 protein kinase inhibitor avaposertib |
| BR112023012947A2 (en) | 2021-10-27 | 2024-04-30 | H Lundbeck As | LRRK2 INHIBITORS |
| CN114163445B (en) * | 2021-12-06 | 2023-06-20 | 重庆医科大学 | Larotinib intermediate and preparation method thereof |
| WO2024054876A1 (en) * | 2022-09-07 | 2024-03-14 | Arvinas Operations, Inc. | Leucine rich repeat kinase 2 (lrrk2) degrading compounds and associated methods of use |
| US11958865B1 (en) | 2022-09-15 | 2024-04-16 | H. Lundbeck A/S | Leucine-rich repeat kinase 2 (LRRK2) inhibitors |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR078675A1 (en) * | 2009-10-20 | 2011-11-23 | Cellzome Ltd | DERIVATIVES OF PIRAZOLO [3,4-D] PYRIMIDINE INHIBITORS OF JAK QUINASAS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, METHOD FOR PREPARING THEM AND USE OF THE SAME FOR THE TREATMENT OR PROFILAXIS OF IMMUNOLOGICAL, INFLAMMATORY AND SELF-IMMUNE DISORDERS. |
| US20130131043A1 (en) * | 2010-04-30 | 2013-05-23 | Richard John Harrison | Pyrazole compounds as jak inhibitors |
| US8637529B2 (en) | 2010-06-11 | 2014-01-28 | AbbYie Inc. | Pyrazolo[3,4-d]pyrimidine compounds |
| MD20140023A2 (en) * | 2011-09-22 | 2014-06-30 | Pfizer Inc. | Pyrrolopyrimidine and purine derivatives |
| SG11201506531WA (en) * | 2013-03-14 | 2015-09-29 | Pfizer | Combination of an egfr t790m inhibitor and an egfr inhibitor for the treatment of non-small cell lung cancer |
| TW201533043A (en) * | 2013-04-18 | 2015-09-01 | Lundbeck & Co As H | Arylpyrrolopyridine derived compounds as LRRK2 inhibitors |
| CR20160348A (en) * | 2014-01-29 | 2017-04-28 | Glaxosmithline Intellectual Property Dev Ltd | COMPOUNDS |
| CN107801397B (en) * | 2015-02-13 | 2021-07-30 | 达纳－法伯癌症研究所公司 | LRRK2 inhibitors and methods of making and using the same |
| WO2017087905A1 (en) * | 2015-11-20 | 2017-05-26 | Denali Therapeutics Inc. | Compound, compositions, and methods |
| US10023579B2 (en) * | 2015-12-16 | 2018-07-17 | Southern Research Institute | Pyrrolopyrimidine compounds, use as inhibitors of the kinase LRRK2, and methods for preparation thereof |
| US11208412B2 (en) * | 2017-02-22 | 2021-12-28 | Daegu-Gyeongbuk Medical Innovation Foundation | Pyrrolo-pyrimidine derivative compound, preparation method therefor, and pharmaceutical composition comprising same compound as effective ingredient for preventing or treating protein kinase-related disease |
| AU2018381574B2 (en) * | 2017-12-05 | 2022-09-15 | Oscotec Inc. | Pyrrolo(pyrazolo)pyrimidine derivative as LRRK2 inhibitor |
-
2018
- 2018-12-03 AU AU2018381574A patent/AU2018381574B2/en active Active
- 2018-12-03 MX MX2020005866A patent/MX2020005866A/en unknown
- 2018-12-03 CA CA3083583A patent/CA3083583A1/en active Pending
- 2018-12-03 WO PCT/KR2018/015184 patent/WO2019112269A1/en unknown
- 2018-12-03 EP EP18886236.1A patent/EP3722298B1/en active Active
- 2018-12-03 SG SG11202005264PA patent/SG11202005264PA/en unknown
- 2018-12-03 JP JP2020550569A patent/JP7230053B2/en active Active
- 2018-12-03 CN CN201880078460.2A patent/CN111433208B/en active Active
- 2018-12-03 EA EA202091372A patent/EA202091372A1/en unknown
- 2018-12-03 US US16/769,667 patent/US11370796B2/en active Active
- 2018-12-03 KR KR1020207014328A patent/KR20200085779A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3722298A1 (en) | 2020-10-14 |
| AU2018381574B2 (en) | 2022-09-15 |
| EP3722298B1 (en) | 2023-08-02 |
| JP2021505679A (en) | 2021-02-18 |
| CN111433208A (en) | 2020-07-17 |
| US20210363144A1 (en) | 2021-11-25 |
| EP3722298A4 (en) | 2021-04-14 |
| US11370796B2 (en) | 2022-06-28 |
| MX2020005866A (en) | 2020-09-09 |
| KR20200085779A (en) | 2020-07-15 |
| WO2019112269A1 (en) | 2019-06-13 |
| CA3083583A1 (en) | 2019-06-13 |
| EA202091372A1 (en) | 2020-10-05 |
| JP7230053B2 (en) | 2023-02-28 |
| AU2018381574A1 (en) | 2020-07-16 |
| CN111433208B (en) | 2023-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202005264PA (en) | Pyrrolo(pyrazolo)pyrimidine derivative as lrrk2 inhibitor | |
| ZA201808431B (en) | Pyrazolopyrimidine derivatives as kinase inhibitor | |
| IL254224A0 (en) | 7-substituted-5-alkyl-[1,2,4] triazolo[1,5-a]pyrimidine derivatives as pde2 inhibitors | |
| HK1252752A1 (en) | Novel pyrazolo pyrimidine derivatives | |
| HK1258157A1 (en) | Pyrazolo[1,5-a]pyrazin-4-yl derivatives as jak-inhibitors | |
| IL266305B (en) | [1,2,4]triazolo[1,5-a]pyrimidine derivatives as pde2 inhibitors | |
| SI3322706T1 (en) | Substituted pyrazolo(1,5-a)pyridine compounds as ret kinase inhibitors | |
| ZA202000561B (en) | Pyrazolo and triazolo bicyclic compounds as jak kinase inhibitors | |
| IL282386A (en) | Aminopyrimidine/pyrazine derivatives as ctps1 inhibitors | |
| EP3328840A4 (en) | Substituted triazolo bicyclic compounds as pde2 inhibitors | |
| ZA201605666B (en) | Pyrazolo[1,5-a]pyrimidines as antiviral compounds | |
| IL262673A (en) | Pyrazolo[1,5-a]pyrimidine compound | |
| IL290419A (en) | Imidazo [1,5-a] pyrazine derivatives as pi3kdelta inhibitors | |
| EP3196199A4 (en) | Substituted n-(pyrrolidine-3-yl)-7h-pyrrolo[2,3-d]pyrimidine-4-amine as janus kinase inhibitor | |
| EP3313852A4 (en) | Substituted pyrazolo/imidazolo bicyclic compounds as pde2 inhibitors | |
| EP3661935A4 (en) | Substituted pyrazolopyrimidines useful as kinases inhibitors | |
| IL269144A (en) | Pyrrolotriazine derivatives as kinase inhibitor | |
| EP3285581A4 (en) | Pyrazolyl pyrimidinone compounds as pde2 inhibitors |